Differential co-expression analysis reveals early stage transcriptomic decoupling in alzheimer’s disease

BACKGROUND: Alzheimer’s disease (AD) is one of the leading causes of death in the US and there is no validated drugs to stop, slow or prevent AD. Despite tremendous effort on biomarker discovery, existing findings are mostly individual biomarkers and provide limited insights into the transcriptomic...

Descripción completa

Detalles Bibliográficos
Autores principales: Upadhyaya, Yurika, Xie, Linhui, Salama, Paul, Cao, Sha, Nho, Kwangsik, Saykin, Andrew J., Yan, Jingwen, Alzheimer’s Disease Neuroimaging Initiative, for the
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118822/
https://www.ncbi.nlm.nih.gov/pubmed/32241275
http://dx.doi.org/10.1186/s12920-020-0689-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118822/
https://www.ncbi.nlm.nih.gov/pubmed/32241275
http://dx.doi.org/10.1186/s12920-020-0689-y

Ejemplares similares